Bioanalysis of tetrahydrobiopterin with liquid chromatographic-mass spectrometric and its application for pharmacokinetics in apolipoprotein E knockout mice

References

• Förstermann, U.; Xia, N.; Li, H. Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis. Circ. Res. 2017, 120, 713–735. DOI: 10.1161/CIRCRESAHA.116.309326.
   PubMed Web of Science ®Google Scholar
• Higashi, Y.; Maruhashi, T.; Noma, K.; Kihara, Y. Oxidative Stress and Endothelial Dysfunction: clinical Evidence and Therapeutic Implications. Trends Cardiovas. Med. 2014, 24, 165–169. DOI: 10.1016/j.tcm.2013.12.001.
   PubMed Web of Science ®Google Scholar
• Zhao, Y.; Vanhoutte, P. M.; Leung, S. W. S. Vascular Nitric Oxide: Beyond eNOS. J. Pharmacol. Sci. 2015, 129, 83–94. DOI: 10.1016/j.jphs.2015.09.002.
   PubMed Web of Science ®Google Scholar
• Yuyun, M. F.; Ng, L. L.; Ng, G. A. Endothelial Dysfunction, Endothelial Nitric Oxide Bioavailability, Tetrahydrobiopterin, and 5-Methyltetrahydrofolate in Cardiovascular Disease. Where Are we with Therapy? Microvasc. Res. 2018, 119, 7–12.
   PubMed Web of Science ®Google Scholar
• Francis, B. N.; Salameh, M.; Khamisy-Farah, R.; Farah, R. Tetrahydrobiopterin (BH 4): Targeting Endothelial Nitric Oxide Synthase as a Potential Therapy for Pulmonary Hypertension. Cardiovasc. Ther. 2018, 36, e12312. DOI: 10.1111/1755-5922.12312.
   Web of Science ®Google Scholar
• Shah, Y.; Bass, L.; Davison, G. W.; Seigler, N.; Pollock, J. S.; Thomas, J.; Harris, R. A. BH4 Improves Postprandial Endothelial Function after a High-Fat Meal in Men and Postmenopausal Women. Menopause 2017, 24, 555–562. DOI: 10.1097/GME.0000000000000785.
   PubMed Web of Science ®Google Scholar
• Alkaitis, M. S.; Crabtree, M. J. Recoupling the Cardiac Nitric Oxide Synthases: tetrahydrobiopterin Synthesis and Recycling. Curr. Heart Fail. Rep. 2012, 9, 200–210. DOI: 10.1007/s11897-012-0097-5.
   PubMedGoogle Scholar
• Rabender, C. S.; Alam, A.; Sundaresan, G.; Cardnell, R. J.; Yakovlev, V. A.; Mukhopadhyay, N. D.; Graves, P.; Zweit, J.; Mikkelsen, R. B. The Role of Nitric Oxide Synthase Uncoupling in Tumor Progression. Mol. Cancer Res. 2015, 13(6), 1034–1043. molcanres-0057.
   PubMed Web of Science ®Google Scholar
• Aviles-Herrera, J.; Arana-Pazos, K. C.; Del, L.; Valle-Mondragon, C. G.-G.; Rubio-Guerra, A. F. Association between bh4/bh2 Ratio and Albuminuria in Hypertensive Type-2 Diabetic Patients. Blood Press. 2017, 175, 8.
   Google Scholar
• Crabtree, M. J.; Channon, K. M. Synthesis and Recycling of Tetrahydrobiopterin in Endothelial Function and Vascular Disease. Nitric Oxide. 2011, 25, 81–88. DOI: 10.1016/j.niox.2011.04.004.
   PubMed Web of Science ®Google Scholar
• Xia, N.; Förstermann, U.; Li, H. Implication of eNOS Uncoupling in Cardiovascular Disease. React. Oxyg. Species., 2017, 3(7), 38–46.
   Google Scholar
• Kim, T.-H.; Choi, J.; Kim, H.-G.; Kim, H. R. Quantification of Neurotransmitters in Mouse Brain Tissue by Using Liquid Chromatography Coupled Electrospray Tandem Mass Spectrometry. J. Anal. Methods Chem. 2014, 2014, 1. DOI: 10.1155/2014/506870.
   Google Scholar
• Fismen, L.; Eide, T.; Djurhuus, R.; Svardal, A. M. Simultaneous Quantification of Tetrahydrobiopterin, Dihydrobiopterin, and Biopterin by Liquid Chromatography Coupled Electrospray Tandem Mass Spectrometry. Anal. Biochem. 2012, 430, 163–170. DOI: 10.1016/j.ab.2012.08.019.
   PubMed Web of Science ®Google Scholar
• van Vliet, D.; Anjema, K.; Jahja, R.; de Groot, M. J.; Liemburg, G. B.; Heiner Fokkema, M. R.; van der Zee, E. A.; Derks, T. G. J.; Kema, I. P.; van Spronsen, F. J. BH4 Treatment in BH4-Responsive PKU Patients: preliminary Data on Blood Prolactin Concentrations Sug- Gest Increased Cerebral Dopamine Concentrations. Mol. Genet. Metab. 2015, 114, 29–33. DOI: 10.1016/j.ymgme.2014.11.009.
   PubMed Web of Science ®Google Scholar
• Fiege, B.; Ballhausen, D.; Kierat, L.; Leimbacher, W.; Goriounov, D.; Schircks, B.; Thöny, B.; Blau, N. Plasma Tetrahydrobiopterin and Its Pharmacokinetic following Oral Administration. Mol. Genet. Metab. 2004, 81, 45–51.
   PubMed Web of Science ®Google Scholar
• Feillet, F.; Clarke, L.; Meli, C.; Lipson, M.; Morris, A. A.; Harmatz, P.; Mould, D. R.; Green, B.; Dorenbaum, A.; Giovannini, M.; et al. Pharmacokinetics of Sapropterin in Patients with Phenylketonuria. Clin. Pharmacokinet. 2008, 47, 817–825. DOI: 10.2165/0003088-200847120-00006..
   PubMed Web of Science ®Google Scholar
• Zurflüh, M. R.; Fiori, L.; Fiege, B.; Ozen, I.; Demirkol, M.; Gärtner, K. H.; Thöny, B.; Giovannini, M.; Blau, N. Pharmacokinetics of Orally Administered Tetrahydrobiopterin in Patients with Phenylalanine Hydroxylase Deficiency. J. Inherit. Metab. Dis. 2006, 29, 725–731. DOI: 10.1007/s10545-006-0425-6.
   PubMed Web of Science ®Google Scholar
• Hayashi, T.; Ogata, A.; Takehisa, M.; Komoriya, K.; Ohnuma, N. Studies on Metabolism and Disposition of Sapropterin Hydrochloride (SUN 0588) L-Erythro- Tetrahydrobiopterin Hydrochloride in Rats. Kiso Rinsho 1992, 26, 3471–3495.
   Google Scholar
• Hoshiga, M.; Hatakeyama, K.; Watanabe, M.; Shimada, M.; Kagamiyama, H. Autoradiographic Distribution of [14C] Tetrahydrobiopterin and Its Developmental Change in Mice. J. Pharmacol. Exp. Ther. 1993, 267, 971–978.
   PubMed Web of Science ®Google Scholar
• Setoodeh, A.; Yarali, B.; Rabbani, A.; Khatami, S.; Shams, S. Tetrahydrobiopterin Responsiveness in a Series of 53 Cases of Phenylketonuria and Hyperphenylalaninemia in Iran. Mol. Genet. Metab. 2015, 2, 77–79. DOI: 10.1016/j.ymgmr.2015.01.001.
   Web of Science ®Google Scholar
• Al Hafid, N.; Christodoulou, J. Phenylketonuria: A Review of Current and Future Treatments. Transl. Pediatr. 2015, 4, 304.
   PubMed Web of Science ®Google Scholar
• Scala, I.; Concolino, D.; Casa, R.; Nastasi, A.; Ungaro, C.; Paladino, S.; Capaldo, B.; Ruoppolo, M.; Daniele, A.; Bonapace, G.; et al. Long-Term Follow-up of Patients with Phenylketonuria Treated with Tetrahydrobiopterin: A Seven Years Experience. Orphanet J. Rare Dis. 2015, 10, 14. DOI: 10.1186/s13023-015-0227-8.
   PubMed Web of Science ®Google Scholar
• Starr, A.; Hussein, D.; Nandi, M. The Regulation of Vascular Tetrahydrobiopterin Bioavailability. Vasc. Pharmacol. 2013, 58, 219–230. DOI: 10.1016/j.vph.2012.08.002.
   PubMed Web of Science ®Google Scholar
• Bendall, J. K.; Douglas, G.; McNeill, E.; Channon, K. M.; Crabtree, M. J. Tetrahydrobiopterin in Cardiovascular Health and Disease. Antioxid. Redox Sign. 2014, 20, 3040–3077. DOI: 10.1089/ars.2013.5566.
   PubMed Web of Science ®Google Scholar
• Fekkes, D.; Voskuilen-Kooijman, A. Quantitation of Total Biopterin and Tetrahydrobiopterin in Plasma. Clin. Biochem. 2007, 40, 411–413. DOI: 10.1016/j.clinbiochem.2006.12.001.
   PubMed Web of Science ®Google Scholar
• Chalupsky, K.; Kračun, D.; Kanchev, I.; Bertram, K.; Görlach, A. Folic Acid Promotes Recycling of Tetrahydrobiopterin and Protects against Hypoxia-Induced Pulmonary Hypertension by Recoupling Endothelial Nitric Oxide Synthase. Antioxid. Redox Sign. 2015, 23, 1076–1091. DOI: 10.1089/ars.2015.6329.
   PubMed Web of Science ®Google Scholar
• Werner, E. R.; Werner-Felmayer, G.; Wachter, H. High-Performance Liquid Chromatographic Methods for the Quantification of Tetrahydrobiopterin Biosynthetic Enzymes. J. Chromatogr. B Biomed. Sci. Appl. 1996, 684, 51–58.
   Web of Science ®Google Scholar
• Zhao, Y.; Cao, J.; Chen, Y.-S.; Zhu, Y.; Patrick, C.; Chien, B.; Cheng, A.; Foehr, E. D. Detection of Tetrahydrobiopterin by LC–MS/MS in Plasma from Multiple Species. Bioanalysis 2009, 1, 895–903. DOI: 10.4155/bio.09.77.
   PubMed Web of Science ®Google Scholar
• Guidance for Industry Bioanalytical Method Validation. US Department of Health and Human Services, US FDA, WA, USA 2001.
   Google Scholar
• Cunnington, C.; Van Assche, T.; Shirodaria, C.; Kylintireas, I.; Lindsay, A. C.; Lee, J. M.; Antoniades, C.; Margaritis, M.; Lee, R.; Cerrato, R. Systemic and Vascular Oxidation Limits Efficacy of Oral Tetrahydrobiopterin Treatment in Patients with Coronary Artery Disease. Circ. 2012, 125(11), 1356–1366. CIRCULATIONAHA-111.
   PubMed Web of Science ®Google Scholar